The chairman of Regulus Therapeutics bought over 370K shares, an Exelixis director sold 50K shares Welcome to "Fly Insider," The Fly's weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from May 6 through May 10 include:
-
CEO of Realogy (RLGY) Ryan Schneider purchased 119,300 shares of company stock at $8.38 per share for a total transaction value of $999,734
-
Chairman of Regulus Therapeutics (RGLS) Stelios Papadopoulos purchased 370,370 shares of company stock at $1.08 per share for a total transaction value of $400,000
-
Chairman of Opko Health (OPK) Phillip Frost purchased 285,000 shares of company stock at $2.06 per share for a total transaction value of $585,789
-
Chairman of Ultra Clean Holdings (UCTT) Clarence Granger purchased 44,000 shares of company stock at $14.18 per share for a total transaction value of $623,902
-
Chairman of Fluor (FLR) Alan Boeckmann purchased 16,000 shares of company stock at $29.81 per share for a total transaction value of $476,960
-
Director of First Financial Bankshares (FFIN) Johnny Trotter purchased 5,000 shares of company stock at $61.29 per share for a total transaction value of $306,450
-
Officer of Genuine Parts (GPC) Scott Sonnemaker purchased 5,000 shares of company stock at $99.01 per share for a total transaction value of $495,050
-
Director of Alleghany Corp (Y) Lauren Tyler purchased 1,485 shares of company stock at an average price of $668.61 for a total transaction value of $992,885
-
Chairman of AG Mortgage Investment Trust (MITT) David Roberts purchased 50,000 shares of company stock at $16.53 per share for a total transaction value of $826,500
-
Director of MGM Resorts International (MGM) purchased 800,000 shares of company stock at an average price of $25.40 per share for a total transaction value of $20,322,240
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from May 6 through May 10 include:
-
CFO of TrueBlue (TBI) Derrek Gafford sold 40,000 shares of company stock at $24.16 per share for a total transaction value of $966,432
-
CEO of American Homes 4 Rent (AMH) David Singelyn sold 1,040,000 shares of company stock at $23.67 per share for a total transaction value of $24,615,448
-
Director of Appfolio (APPF) William Rauth sold 20,000 shares of company stock at $96.11 per share for a total transaction value of $1,922,206
-
Director of Exelixis (EXEL) Lance Willsey sold 50,000 shares of company stock at $20.36 per share for a total transaction value of $1,018,000
-
VP of Hudson Pacific Properties (HPP) Christopher Barton sold 27,756 shares of company stock at $34.67 per share for a total transaction value of $962,228
-
VP of Neenah (NP) Larry Brownlee sold 5,000 shares of company stock at an average price of $62.52 per share for a total transaction value of $312,600
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTIONS: Regulus Therapeutics is up approximately 13%
since its chairman purchased 370,370 shares, while Exelixis is down approximately 9% since a director sold 50,000 shares.
Symbols:
RLGY RGLS OPK UCTT FLR FFIN GPC Y MITT MGM TBI AMH APPF EXEL HPP NP Keywords: nsider trading, insider buying, insider selling, executive trading, executive buying, executive selling, stock transactions, SEC